Journals
Publish with us
Publishing partnerships
About us
Blog
PPAR Research
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
PPAR Research
/
2023
/
Article
/
Fig 1
/
Research Article
Significance of PPARA as a Treatment Target for Chronic Lymphocytic Leukemia
Figure 1
EGR2, FBXW7, RPS15, and FOXO1 mutations were shown to be associated with shorter treatment-free survival (TFS) in 86 patients.